Test ID FSOMA Somatostatin
Method Name
Direct Radioimmunoassay (RIA)
Reporting Name
Somatostatin (Plasma)Specimen Type
GI PlasmaCollect 10 mL of blood in special tube containing G.I. Preservative (MML supply number T125). Specimen should be separated and 3 mL plasma frozen as soon as possible.
Patient preparation:
1) Patient should be fasting 10-12 hours prior to collection.
2) Patient should not be on any antacid medication or medications that affect insulin secretion or intestinal motility, if possible, for at least 48 hours prior to collection.
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
GI Plasma | Frozen | 180 days |
Clinical Information
Somatostatin is a cyclic peptide originally isolated from sheep hypothalami
and shown to inhibit the release of Growth Hormone. Somatostatin is present
primarily in three main forms: a 14 amino acid peptide, a 28 amino acid peptide
(Big Somatostatin), and a 12,000 molecular weight Pro-Somatostatin. This
assay measures only the 14 amino acid form of Somatostatin. All three forms
of Somatostatin have similar biological properties and overall potencies.
Somatostatin is a physiological regulator of islet cell and gastrointestinal functions,
and is a suppressor of many pituitary hormones including Growth Hormone, Prolactin,
and Thyrotropin (TSH). Somatostatin levels are often elevated in diabetics, but the
levels return to normal upon correction of the hormonal and metabolic deficiencies
present. In many cases of APUDomas including VIPoma, Insulinoma, Glucagonoma,
and Gastrinoma, elevated levels of Somatostatin are found.
Reference Values
Up to 25 pg/ml
This test was developed and its performance characteristics
determined by Inter Science Institute. It has not been cleared or
approved by the US Food and Drug Administration. The FDA
has determined that such clearance or approval is not necessary.
Day(s) Performed
Monday through Friday
Report Available
5 - 7 daysPerforming Laboratory
Inter Science InstituteTest Classification
This test was developed and its performance characteristics determined by Inter Science Institute. It has not been cleared or approved by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.CPT Code Information
84307